Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.

Abstract: Disclosed herein are systems and architecture for thermal waveguide-based phase shifters which improve thermal efficiency by having multi-pass waveguides arranged under the heating element in a serpentine fashion, with the waveguides having mismatched propagation constants. The combination allows for an increase in phase shift without increasing the length or the power consumption of the resistive heating element by increasing the total length of waveguide being heated by a singular heating element.

Abstract: The present invention relates to a topical pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt thereof and a corticosteroid or a pharmaceutically acceptable salt thereof, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with a combination of alcaftadine or a pharmaceutically acceptable salt thereof and a corticosteroid or a pharmaceutically acceptable salt thereof, and methods of preparing the topical composition.

Abstract: Disclosed herein are systems and architecture for thermal waveguide-based phase shifters which improve thermal efficiency by having multi-pass waveguides arranged under the heating element in a serpentine fashion, with the waveguides having mismatched propagation constants. The combination allows for an increase in phase shift without increasing the length or the power consumption of the resistive heating element by increasing the total length of waveguide being heated by a singular heating element.

Abstract: Disclosed herein are systems and architecture for thermal waveguide-based phase shifters which improve thermal efficiency by having multi-pass waveguides arranged under the heating element in a serpentine fashion, with the waveguides having mismatched propagation constants. The combination allows for an increase in phase shift without increasing the length or the power consumption of the resistive heating element by increasing the total length of waveguide being heated by a singular heating element.

Abstract: An ethylene/alpha-olefin interpolymer suitable for use in fibers and nonwovens having a density of from 0.911 to 0.939 g/cc, a Brookfield viscosity of less than or equal to 50,000 cP, and a molecular weight distribution (Mw,cc/Mn,cc) of 1.8 to 3.5, and articles thereof.

Abstract: Disclosed herein are systems and architecture for thermal waveguide-based phase shifters which improve thermal efficiency by having multi-pass waveguides arranged under the heating element in a serpentine fashion, with the waveguides having mismatched propagation constants. The combination allows for an increase in phase shift without increasing the length or the power consumption of the resistive heating element by increasing the total length of waveguide being heated by a singular heating element.

Abstract: Laminate film structures including an adhesive layer having gas and moisture barrier properties are disclosed. The disclosed laminate film structures comprise films bonded together with an adhesive composition, the adhesive composition having barrier properties, e.g., controlling oxygen and/or water vapor transmission rates. The disclosed laminate film structures comprise films made from polymers and/or metallized polymers whereby the weight, thickness, and/or number of film layers has been reduced by using a barrier adhesive in place of a standard adhesive while still achieving similar barrier properties.

Abstract: The present disclosure provides a packaging article (10). In an embodiment, the packaging article comprises (A) a rigid container (12) having side walls (14) and a bottom wall (16), the walls defining a compartment (20), and (B) a sheet (22) of 3-dimensional random loop material (3DRLM) in the compartment. A food item (C) may be located in the compartment, the food item contacts the sheet of 3DRLM.

Abstract: A cushioning network structure comprising a plurality of random loops arranged in a three-dimensional orientation, wherein the plurality of random loops are formed from an ethylene/a-olefin interpolymer composition having a highest DSC temperature melting peak in the range of from 90.0° C. to 115.0° C.; a zero shear viscosity ratio (ZSVR) in the range from 1.40 to 2.10; a density in the range of from 0.860 to 0.925 g/cc, a melt index (12) in a range of from 1 to 25 g/10 minutes when measured according to ASTM D1238 at 190° C. and 2.16 kg, a molecular weight distribution (Mw/Mn) in the range of from 2.0 to 4.5.

Abstract: An ethylene/alpha-olefin interpolymer suitable for use in fibers and nonwovens having a density of from 0.911 to 0.939 g/cc, a Brookfield viscosity of less than or equal to 50,000 cP, and a molecular weight distribution (Mw,cc/Mn,cc) of 1.8 to 3.5, and articles thereof.

Abstract: The present disclosure relates to a method of promoting optimal stretching of stretch film during a wrapping operation, which method comprises at least the following steps. First a resin suitable for making stretch films is selected. Then a dispersed agent is selected, preferably one which has a refractive index similar to the selected resin such that when a film is made comprising the resin and the dispersed agent, the film will appear somewhat clear. The dispersed agent is then mixed with the resin and a film is formed from the resin containing the dispersed agent. Finally, a load is manually wrapped using such film, wherein during wrapping, the film is stretched to a level where the film becomes more opaque.

Abstract: A cushioning network structure comprising a plurality of random loops arranged in a three-dimensional orientation, wherein the plurality of random loops are formed from an ethylene/a-olefin interpolymer composition having a highest DSC temperature melting peak in the range of from 90.0° C. to 115.0° C.; a zero shear viscosity ratio (ZSVR) in the range from 1.40 to 2.10; a density in the range of from 0.860 to 0.925 g/cc, a melt index (12) in a range of from 1 to 25 g/10 minutes when measured according to ASTM D1238 at 190° C. and 2.16 kg, a molecular weight distribution (Mw/Mn) in the range of from 2.0 to 4.5.

Abstract: Breathable films formed from polyethylene are provided that can have desirable properties. In one aspect, a breathable film comprises a layer formed from a composition comprising a first composition, wherein the first composition comprises at least one ethylene-based polymer and wherein the first composition comprises a MWCDI value greater than 0.9, and a melt index ratio (I10/I2) that meets the following equation: I10/I2?7.0?1.2×log(I2).